Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH/PTHrP receptor.

Ohishi, Masanobu

Osteoprotegerin abrogated cortical porosity and bone marrow fibrosis in a mouse model of constitutive activation of the PTH/PTHrP receptor. [electronic resource] - The American journal of pathology Jun 2009 - 2160-71 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1525-2191

10.2353/ajpath.2009.081026 doi


Alendronate--pharmacology
Animals
Biomechanical Phenomena
Bone Resorption--metabolism
Bone and Bones--drug effects
Diphosphonates--pharmacology
Disease Models, Animal
Humans
Hyperparathyroidism--metabolism
Imidazoles--pharmacology
Immunohistochemistry
Male
Mice
Mice, Transgenic
Osteoclasts--drug effects
Osteoprotegerin--metabolism
Porosity
Primary Myelofibrosis--metabolism
Receptor, Parathyroid Hormone, Type 1--genetics
Tomography, X-Ray Computed
Zoledronic Acid